Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress

Acta Psychiatrica Scandinavica

Volumn 125, Issue 3, 2012, Pages 247-256

  Peerbooms, O ^a   Rutten, B P F ^a   Collip, D ^a   Lardinois, M ^a   Lataster, T ^a   Thewissen, V ^a,b   Mafi Rad, S ^a   Drukker, M ^a   Kenis, G ^a   Van Os, J ^a,c   Myin Germeys, I ^a,d   Van Winkel, R ^a,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Mondriaan Zorggroep   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Environment; Epigenesis; Epistasis; Psychotic disorder; Stress

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CATECHOL METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; COGNITION; CONTROLLED STUDY; EDUCATIONAL STATUS; ENVIRONMENTAL STRESS; FEMALE; GENE INTERACTION; GROUPS BY AGE; HUMAN; LIFE STRESS; MALE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTATION, PSYCHOLOGICAL; ADULT; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHOTIC DISORDERS; RESILIENCE, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84856975637     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01806.x     Document Type: Article

References (46)

1. Fan JB, Zhang CS, Gu NF et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 2005;57:139-144.
2. Munafo MR, Bowes L, Clark TG, Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005;10:765-770.
3. Okochi T, Ikeda M, Kishi T et al. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 2009;110:140-148.
4. Mier D, Kirsch P, Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2009;15:918-927.
5. Papaleo F, Crawley JN, Song J et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 2008;28:8709-8723.
6. Collip D, Van Winkel R, Peerbooms O et al. COMT Val158Met-stress interaction in psychosis: role of background psychosis risk. CNS Neurosci Ther 2011; doi: 10.1111/j.17555949.2010.00213.x. [E.pub ahead of print].
7. Van Winkel R, Henquet C, Rosa A et al. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am J Med Genet B Neuropsychiatr Genet 2008;147B:10-17.
8. Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, Van Os J. Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med 2009;39:1533-1547.
9. Van Winkel R, Stefanis NC, Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008;34:1095-1105.
10. Nicodemus KK, Kolachana BS, Vakkalanka R et al. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet 2007;120:889-906.
11. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
12. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-172.
13. Weisberg IS, Jacques PF, Selhub J et al. The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001;156:409-415.
14. Van Der Put NM, Gabreels F, Stevens EM et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-1051.
15. Allen NC, Bagade S, Mcqueen MB et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008;40:827-834.
16. Shi J, Gershon ES, Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 2008;104:96-107.
17. Sugden C. One-carbon metabolism in psychiatric illness. Nutr Res Rev 2006;19:117-136.
18. Chen J, Lipska BK, Halim N et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004;75:807-821.
19. Sasaki M, Kaneuchi M, Sakuragi N, Dahiya R. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Cancer Res 2003;63:3101-3106.
20. Muntjewerff JW, Gellekink H, Den Heijer M et al. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia. Eur Neuropsychopharmacol 2008;18:99-106.
21. Roffman JL, Gollub RL, Calhoun VD et al. MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met. Proc Natl Acad Sci U S A 2008;105:17573-17578.
22. Roffman JL, Weiss AP, Deckersbach T et al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008;147B:990-995.
23. Lataster T, Collip D, Lardinois M, Van Os J, Myin-Germeys I. Evidence for a familial correlation between increased reactivity to stress and positive psychotic symptoms. Acta Psychiatr Scand 2010;122:395-404.
24. Thewissen V, Bentall RP, Lecomte T, Van Os J, Myin-Germeys I. Fluctuations in self-esteem and paranoia in the context of daily life. J Abnorm Psychol 2008;117:143-153.
25. APA. Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC: APA, 1994.
26. Mcguffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991;48:764-770.
27. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992;49:615-623.
28. Csikszentmihalyi M, Larson R. Validity and reliability of the Experience-Sampling Method. J Nerv Ment Dis 1987;175:526-536.
29. Delespaul P, Devries M, Van Os J. Determinants of occurrence and recovery from hallucinations in daily life. Soc Psychiatry Psychiatr Epidemiol 2002;37:97-104.
30. Glaser JP, Van Os J, Thewissen V, Myin-Germeys I. Psychotic reactivity in borderline personality disorder. Acta Psychiatr Scand 2010;121:125-134.
31. Henquet C, Rosa A, Delespaul P et al. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr Scand 2009;119:156-160.
32. Lardinois M, Lataster T, Mengelers R, Van Os J, Myin-Germeys I. Childhood trauma and increased stress sensitivity in psychosis. Acta Psychiatr Scand 2010;123:28-35.
33. Lardinois M, Myin-Germeys I, Bak M, Mengelers R, Van Os J, Delespaul PA. The dynamics of symptomatic and non-symptomatic coping with psychotic symptoms in the flow of daily life. Acta Psychiatr Scand 2007;116:71-75.
34. Mccormick BP, Frey GC, Lee CT, Gajic T, Stamatovic-Gajic B, Maksimovic M. A pilot examination of social context and everyday physical activity among adults receiving Community Mental Health Services. Acta Psychiatr Scand 2009;119:243-247.
35. Myin-Germeys I, Delespaul P, Van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med 2005;35:733-741.
36. Myin-Germeys I, Peeters F, Havermans R et al. Emotional reactivity to daily life stress in psychosis and affective disorder: an experience sampling study. Acta Psychiatr Scand 2003;107:124-131.
37. Myin-Germeys I, Van Os J. Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev 2007;27:409-424.
38. Myin-Germeys I, Van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 2001;58:1137-1144.
39. Oorschot M, Kwapil T, Delespaul P, Myin-Germeys I. Momentary assessment research in psychosis. Psychol Assess 2009;21:498-505.
40. Palmier-Claus JE, Myin-Germeys I, Barkus E et al. Experience sampling research in individuals with mental illness: reflections and guidance. Acta Psychiatr Scand 2011;123:12-20.
41. Simons CJ, Wichers M, Derom C et al. Subtle gene-environment interactions driving paranoia in daily life. Genes Brain Behav 2009;8:5-12.
42. Wichers MC, Myin-Germeys I, Jacobs N et al. Evidence that moment-to-moment variation in positive emotions buffer genetic risk for depression: a momentary assessment twin study. Acta Psychiatr Scand 2007;115:451-457.
43. Schwartz JE, Stone AA. Strategies for analyzing ecological momentary assessment data. Health Psychol 1998;17:6-16.
44. STATACORP. Stata statistical software, release 10.0. College Station, TX: Stata Corporation, 2007.
45. Mattay VS, Goldberg TE, Fera F et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 2003;100:6186-6191.
46. Moffitt TE, Caspi A, Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 2005;62:473-481.